Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients.

By H. Hirsch, W. Knowles, M. Dickenmann, J. Passweg, T. Klimkait, M. Mihatsch, J. Steiger. New England Journal of Medicine, 2002

1,190 citations recorded by the source corpus.

Subfields: Infectious Diseases, Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/4101591ca523315eaad33dc20380c3c6ee8f0353

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. H. Hirsch
2. D. Brennan
3. M. Tomblyn
4. A. Egli
5. C. Drachenberg
6. T. Chiller
7. F. Ginevri
8. L. Infanti

Citations in the corpus

• Incidence of BK with Tacrolimus Versus Cyclosporine and Impact of Preemptive Immunosuppression Reduction (2005, background): “30–35% of renal transplant recipients (5,6).”
• Polyomavirus-Associated Nephropathy in Renal Transplantation: Interdisciplinary Analyses and Recommendations (2005, background): “In reports from 2002–2003, the prevalence of PVAN ranges from 1% to 10% (Table 2), which corresponds to Kaplan-Meier estimates for the incidence of PVAN (8%, 95% CI: 1–15%) (13).”
• Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplant Recipients: A Global Perspective (2009, background): “There are reports of sporadic cases of JCV-associated PVHC [355], BKV- or JCV-associated polyomavirus nephropathy (PVAN) [347,356-359], and JCV- or BKV-mediated polyomavirus multifocal leukoencephalopathy (PVML) [360,361].”
• Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. (2009, background): “omavirus pathogenesis and diagnosis [8, 9].”